Please assess the completion status of the following clinical trial:

Trial Title: Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~1. Patients with essential hypertension whose blood pressure is not adequately controlled by amlodipine or telmisartan monotherapy (=140/90 mmHg, = 130/80 mmHg for those with diabetes or kidney disease)~2. Age = 19 years at enrollment~3. Male or female patient (or legally acceptable representative) willing and able to provide written informed consent~Exclusion criteria:~1. Patients with previous exposure to Twynsta~2. Patients with hypersensitivity to the active substances, or to dihydropyridine derivatives~3. Female patients at second and third trimesters of pregnancy~4. Female patients with lactation~5. Patients with biliary obstructive disorders~6. Patients with severe hepatic impairment~7. Patients with high grade aortic stenosis~8. Patients with shock~9. Patients with hereditary conditions such as intolerance with excipient of the products~10. Current participation in other clinical trials or observational studies

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with essential hypertension (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).